NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Griffin, the GOP donor and billionaire founder of hedge fund Citadel, said “favoritism” toward certain companies undermines free-market principles.Read More